3-(3-Pyridyl)-1,3-dihydropyrrolo[1,2-c]thiazole-7-carboxamide - CAS 93363-11-2
Catalog: |
BB040858 |
Product Name: |
3-(3-Pyridyl)-1,3-dihydropyrrolo[1,2-c]thiazole-7-carboxamide |
CAS: |
93363-11-2 |
Synonyms: |
3-(3-pyridinyl)-1,3-dihydropyrrolo[1,2-c]thiazole-7-carboxamide; 3-pyridin-3-yl-1,3-dihydropyrrolo[1,2-c][1,3]thiazole-7-carboxamide |
IUPAC Name: | 3-pyridin-3-yl-1,3-dihydropyrrolo[1,2-c][1,3]thiazole-7-carboxamide |
Description: | 3-(3-Pyridyl)-1,3-dihydropyrrolo[1,2-c]thiazole-7-carboxamide (CAS# 93363-11-2 ) is a useful research chemical. |
Molecular Weight: | 245.30 |
Molecular Formula: | C12H11N3OS |
Canonical SMILES: | C1C2=C(C=CN2C(S1)C3=CN=CC=C3)C(=O)N |
InChI: | InChI=1S/C12H11N3OS/c13-11(16)9-3-5-15-10(9)7-17-12(15)8-2-1-4-14-6-8/h1-6,12H,7H2,(H2,13,16) |
InChI Key: | ARFOASMERCHFBY-UHFFFAOYSA-N |
Boiling Point: | 516.4 °C at 760 mmHg |
Density: | 1.49 g/cm3 |
LogP: | 2.65990 |
Publication Number | Title | Priority Date |
JP-H09227411-A | Remedy for neuropathy caused by spinal cord injury | 19960226 |
JP-H09208493-A | Gram-positive sepsis treatment agent | 19960126 |
JP-H07304689-A | Fulminant hepatitis and acute liver failure therapeutic agent | 19940510 |
EP-0628047-A1 | Novel therapeutical use of pyridylpyrrolothiazole carboxamide derivatives | 19920225 |
WO-9317027-A1 | Novel therapeutical use of pyridylpyrrolothiazole carboxamide derivatives | 19920225 |
PMID | Publication Date | Title | Journal |
10841793 | 20000601 | Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication | Journal of medicinal chemistry |
9087512 | 19970401 | Effects of RP 55778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides | Antimicrobial agents and chemotherapy |
7515938 | 19940601 | Infection of human macrophages with an endogenous tumour necrosis factor-alpha (TNF-alpha)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-alpha synthesis inhibitor RP 55778 | The Journal of general virology |
7681601 | 19930315 | A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells | Proceedings of the National Academy of Sciences of the United States of America |
Complexity: | 312 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 245.06228316 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 245.06228316 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 86.2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS